<html>
<head>
<title>D075.P.100.B.27.WSJ880603-0129</title>
</head>
<body bgcolor="white">
<a name="1">[1]</a> <a href="#1" id=1>Doctors should be cautious in prescribing aspirin as a preventer of heart attacks until more research supports its value, the Food and Drug Administration said.</a>
<a name="2">[2]</a> <a href="#2" id=2>Taking aspirin to prevent heart attacks may increase some people's chances of dying of other things, especially hemorrhagic strokes, the agency said in a commentary in today's Journal of the American Medical Association.</a>
<a name="3">[3]</a> <a href="#3" id=3>The FDA persuaded aspirin makers in March to refrain from promoting aspirin as a preventer of first heart attacks, at least for now.</a>
<a name="4">[4]</a> <a href="#4" id=4>A study published in January indicated an aspirin every other day reduced the risk of nonfatal, first heart attacks 47% in 11,000 male doctors over five years, compared with 11,000 who took a non-aspirin substitute.</a>
<a name="5">[5]</a> <a href="#5" id=5>The FDA commentary pointed to 10 hemorrhagic strokes recorded among the 11,000 subjects taking aspirin in the recent study, compared with two such strokes among 11,000 subjects taking the substitute.</a>
<a name="6">[6]</a> <a href="#6" id=6>She added in a telephone interview yesterday that an extension of the study is under way, and researchers expect to report to the FDA in late fall.</a>
</body>
</html>
